Cases 11 - 20 of 54
Genentech, Inc. et al v. InvaGen Pharmaceuticals, Inc., et al.
as 1:2019cv00219
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Cipla Limited, InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. InvaGen Pharmaceuticals, Inc.
as 1:2018cv01788
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as NJ/2:18-cv-02620
Plaintiff:
SUMITOMO DAINIPPON PHARMA CO., LTD. and SUNOVION PHARMACEUTICALS INC.
Defendant:
AUROBINDO PHARMA LTD. , DR. REDDY'S LABORATORIES, LTD. , DR. REDDY'S LABORATORIES, INC. and others
Sumitomo Dainippon Pharma Co., Ltd. et al v. InvaGen Pharmaceuticals Inc.
as NYE/1:18-cv-01444
Plaintiff:
Sumitomo Dainippon Pharma Co., Ltd. and Sunovion Pharmaceuticals Inc.
Defendant:
InvaGen Pharmaceuticals Inc.
Sumitomo Dainippon Pharma Co., Ltd. et al v. InvaGen Pharmaceuticals Inc.
as 1:2018cv01444
Plaintiff:
Sunovion Pharmaceuticals Inc. and Sumitomo Dainippon Pharma Co., Ltd.
Defendant:
InvaGen Pharmaceuticals Inc.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 2:2018cv02620
Plaintiff:
SUMITOMO DAINIPPON PHARMA CO., LTD. and SUNOVION PHARMACEUTICALS INC.
Defendant:
AUROBINDO PHARMA LTD., DR. REDDY'S LABORATORIES, LTD., DR. REDDY'S LABORATORIES, INC. and others
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. INVAGEN PHARMACEUTICALS, INC.,
as 3:2017cv06375
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
INVAGEN PHARMACEUTICALS, INC.,
Counter_claimant:
INVAGEN PHARMACEUTICALS, INC.,
Counter_defendant:
CILAG GMBH INTERNATIONAL , JANSSEN PHARMACEUTICA NV , JANSSEN PHARMACEUTICALS, INC. and others
Cause Of Action: 15 U.S.C. § 1126
AstraZeneca LP et al v. InvaGen Pharmaceuticals Inc.
as 1:2017cv01073
Plaintiff:
AstraZeneca LP , AstraZeneca AB , AstraZeneca UK Limited and others
Defendant:
InvaGen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 145
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. et al
as 3:2017cv05005
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
AUROBINDO PHARMA USA, INC., INVAGEN PHARMACEUTICALS, INC., MACLEODS PHARMACEUTICALS, LTD. and others
Cause Of Action: 15 U.S.C. § 1126
Bayer Intellectual Property GMBH et al v. InvaGen Pharmaceuticals, Inc.
as 1:2017cv00812
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
